These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
579 related articles for article (PubMed ID: 15270726)
41. 4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation. Shin SM; Kim YH; Choi BK; Kwon PM; Lee HW; Kwon BS J Leukoc Biol; 2007 Jun; 81(6):1455-65. PubMed ID: 17389581 [TBL] [Abstract][Full Text] [Related]
42. Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells. Kondo K; Okuma K; Tanaka R; Zhang LF; Kodama A; Takahashi Y; Yamamoto N; Ansari AA; Tanaka Y Hum Immunol; 2007 Jul; 68(7):563-71. PubMed ID: 17584577 [TBL] [Abstract][Full Text] [Related]
43. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy. Chen HW; Liao CH; Ying C; Chang CJ; Lin CM Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844 [TBL] [Abstract][Full Text] [Related]
44. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination. Du X; Zheng G; Jin H; Kang Y; Wang J; Xiao C; Zhang S; Zhao L; Chen A; Wang B J Gene Med; 2007 Feb; 9(2):136-46. PubMed ID: 17310492 [TBL] [Abstract][Full Text] [Related]
45. Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy. Choi BK; Kim YH; Kang WJ; Lee SK; Kim KH; Shin SM; Yokoyama WM; Kim TY; Kwon BS Cancer Res; 2007 Sep; 67(18):8891-9. PubMed ID: 17875731 [TBL] [Abstract][Full Text] [Related]
46. Cooperation between CD4 and CD8 T cells for anti-tumor activity is enhanced by OX40 signals. Song A; Song J; Tang X; Croft M Eur J Immunol; 2007 May; 37(5):1224-32. PubMed ID: 17429847 [TBL] [Abstract][Full Text] [Related]
47. 4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner. Miller RE; Jones J; Le T; Whitmore J; Boiani N; Gliniak B; Lynch DH J Immunol; 2002 Aug; 169(4):1792-800. PubMed ID: 12165501 [TBL] [Abstract][Full Text] [Related]
48. Molecular and biological characterization of human 4-1BB and its ligand. Alderson MR; Smith CA; Tough TW; Davis-Smith T; Armitage RJ; Falk B; Roux E; Baker E; Sutherland GR; Din WS Eur J Immunol; 1994 Sep; 24(9):2219-27. PubMed ID: 8088337 [TBL] [Abstract][Full Text] [Related]
49. Regulation of CD4 T cell memory by OX40 (CD134). Salek-Ardakani S; Croft M Vaccine; 2006 Feb; 24(7):872-83. PubMed ID: 16176850 [TBL] [Abstract][Full Text] [Related]
50. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model. Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650 [TBL] [Abstract][Full Text] [Related]
51. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. Melero I; Johnston JV; Shufford WW; Mittler RS; Chen L Cell Immunol; 1998 Dec; 190(2):167-72. PubMed ID: 9878117 [TBL] [Abstract][Full Text] [Related]
52. Cloning and expression of murine CD27: comparison with 4-1BB, another lymphocyte-specific member of the nerve growth factor receptor family. Gravestein LA; Blom B; Nolten LA; de Vries E; van der Horst G; Ossendorp F; Borst J; Loenen WA Eur J Immunol; 1993 Apr; 23(4):943-50. PubMed ID: 8384562 [TBL] [Abstract][Full Text] [Related]
53. Unified immune modulation by 4-1BB triggering leads to diverse effects on disease progression in vivo. Choi BK; Kim YH; Choi JH; Kim CH; Kim KS; Sung YC; Lee YM; Moffett JR; Kwon BS Cytokine; 2011 Sep; 55(3):420-8. PubMed ID: 21700476 [TBL] [Abstract][Full Text] [Related]
54. Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB. Sharma S; Dominguez AL; Lustgarten J Exp Gerontol; 2006 Jan; 41(1):78-84. PubMed ID: 16289924 [TBL] [Abstract][Full Text] [Related]
58. Characterisation of soluble murine CD137 and its association with systemic lupus. Shao Z; Sun F; Koh DR; Schwarz H Mol Immunol; 2008 Sep; 45(15):3990-9. PubMed ID: 18640726 [TBL] [Abstract][Full Text] [Related]
59. Characterization of rat OX40 ligand by monoclonal antibody. Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947 [TBL] [Abstract][Full Text] [Related]
60. LIGHT is dispensable for CD4+ and CD8+ T cell and antibody responses to influenza A virus in mice. Sedgmen BJ; Dawicki W; Gommerman JL; Pfeffer K; Watts TH Int Immunol; 2006 May; 18(5):797-806. PubMed ID: 16569673 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]